Tenofovir Disoproxil Fumarate With Emtricitabine And Efavirenz
Recommended · restricted Infectious diseaseAuthority RequiredNot applicable line
Treatment of HIV infection in patients with CD4 cell counts of less than 500 per cubic millimetre or viral load of greater than 10,000 copies per mL.
1
Submissions
2009–09
On the record
—
ICER range
Cost-min
Cost basis
Access path
- Nov 2009Recommended · restricted
vs concomitant use of the individual components (tenofovir…
- PBS listing · Authority Required
RecommendedDeferredNot recommended
Cost-effectiveness
Cost-minimisation analysis; no ICER calculated.
The submission presented a cost-minimisation analysis. PSD · 2009
Decision context
PopulationHIV infected adults over the age of 18 years with CD4 cell counts of less than 500 per cubic millimetre or viral load of greater than 10,000 copies per mL.
Submission history
| Decided | Outcome | Comparator | ICER | Evidence |
|---|---|---|---|---|
| Nov 2009 | Recommended · restricted | concomitant use of the individual components (tenofovir disoproxil fumarate, emtricitabine and efavirenz) | — | Single-arm |